Published • loading... • Updated
Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks
Summary by 24/7 Wall St.
2 Articles
2 Articles
24/7 Wall St.Reposted by 
BizToc
BizTocCantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks
Cantor Fitzgerald just bumped price targets on Eli Lilly, AbbVie, Merck, and Pfizer, but higher targets do not mean equal conviction. The firm's split between Overweight and Neutral ratings reveals a sharp divide in where analysts see real upside and where near-term catalysts could disappoint.
·Lakewood, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
